Microglial degeneration in the aging brain--bad news for neurons?

Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA.
Frontiers in Bioscience (Impact Factor: 3.52). 02/2008; 13(9):3423-38.
Source: PubMed


We have long promulgated the idea that microglial cells serve an entirely beneficial role in the central nervous system (CNS), not only as immunological sentinels to fend off potentially dangerous infections, but also as constitutively neuroprotective glia that help sustain neuronal function in the normal and especially in the injured CNS when microglia become activated. In recent years, we have reported on the presence of degenerating microglial cells, which are prominent in the brains of aged humans and humans with neurodegenerative diseases, and this has led us to propose a hypothesis stating that loss of microglia and microglial neuroprotective functions could, at least in part, account for aging-related neurodegeneration. In the current review, we sum up the many aspects that characterize microglial activation and compare them to those that characterize microglial senescence and degeneration. We also consider the possible role of oxidative stress as a cause of microglial degeneration. We finish up by discussing the role microglial cells play in terms of amyloid clearance and degradation with the underlying idea that removal of amyloid constitutes a microglial neuroprotective function, which may become compromised during aging.

Download full-text


Available from: Kelly Miller, Aug 06, 2014
  • Source
    • "Microglia is activated in the presence of aggregated forms of α-synuclein (Zhang et al., 2005), expressing macrophage markers and releasing IL-1β, IL-6 and TNF-α which can damage the DAc (Croisier et al., 2005; Orr et al., 2005). This activation has been found in both PD (Hunot et al., 1996; Knott et al., 2000) and aged brains (Godbout and Johnson, 2004; Gelinas and McLaurin, 2005; Campuzano et al., 2009), suggesting that the neurotoxic action of these cells is similar in both conditions (Ouchi et al., 2005; Streit et al., 2008; Cunningham, 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Available data show marked similarities for the degeneration of dopamine cells in Parkinson's disease (PD) and aging. The etio-pathogenic agents involved are very similar in both cases, and include free radicals, different mitochondrial disturbances, alterations of the mitophagy and the ubiquitin-proteasome system. Proteins involved in PD such as α-synuclein, UCH-L1, PINK1 or DJ-1, are also involved in aging. The anomalous behavior of astrocytes, microglia and stem cells of the subventricular zone (SVZ) also changes similarly in aging brains and PD. Present data suggest that PD could be the expression of aging on a cell population with high vulnerability to aging. The future knowledge of mechanisms involved in aging could be critical for both understanding the etiology of PD and developing etiologic treatments to prevent the onset of this neurodegenerative illness and to control its progression.
    Frontiers in Neuroanatomy 08/2014; 8:80. DOI:10.3389/fnana.2014.00080 · 3.54 Impact Factor
    • "While the concept of monocyte/macrophage diversity due to origin and location has a longer history (Treves, 1984; Naito et al., 1996; Sunderkotter et al., 2004), a conscious transfer to microglia could now take ground as well. More and more studies also address microglia in the aging brain, variations by species and gender or the surprising differences among individuals (Mouton et al., 2002; Meeuwsen et al., 2005; Sierra et al., 2007; Streit et al., 2008). Analyses of this kind may need to deal with a sophisticated characterization of microglial properties at close inspection and even at the single-cell level. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Microglia serve in the surveillance and maintenance, protection and restoration of the central nervous system (CNS) homeostasis. By their parenchymal location they differ from other CNS-associated myeloid cells, and by origin as well as functional characteristics they are also-at least in part-distinct from extraneural tissue macrophages. Nevertheless, microglia themselves may not comprise a uniform cell type. CNS regions vary by cellular and chemical composition, including white matter (myelin) content, blood-brain barrier properties or prevailing neurotransmitters. Such a micromilieu could instruct as well as require local adaptions of microglial features. Yet even cells within circumscribed populations may reveal some specialization by subtypes, regarding house-keeping duties and functional capacities upon challenges. While diversity of reactive phenotypes has been established still little is known as to whether all activated cells would respond with the same program of induced genes and functions or whether responder subsets have individual contributions. Preferential synthesis of a key cytokine could asign a master control to certain cells among a pool of activated microglia. Critical functions could be sequestered to discrete microglial subtypes in order to avoid interference, such as clearance of endogenous material and presentation of antigens. Indeed, several and especially a number of recent studies provide evidence for the constitutive and reactive heterogeneity of microglia by and within CNS regions. While such a principle of "division of labor" would influence the basic notion of "the" microglia, it could come with the practival value of addressing separate microglia types in experimental and therapeutic manipulations.
    Frontiers in Cellular Neuroscience 05/2013; 7:65. DOI:10.3389/fncel.2013.00065 · 4.29 Impact Factor
  • Source
    • "Furthermore, microglia exhibit partial or complete fragmentation of cytoplasm, as well as nuclear condensation, when exposed to UCB for longer periods of time (Silva et al., 2010), thus compromising any beneficial effect that they could have in BIND protection. This feature is designed as dystrophy of microglia (Streit et al., 2008), or cytorrhexis (Fendrick et al., 2007; Hasegawa- Ishii et al., 2011) and is an indication of microglia degeneration and senescence (Streit et al., 2004). Collectively, we may assume that the release of cytokines and, eventually other soluble products from microglia activated by damaged neurons, contributes to the initiation and maintenance of astrogliosis observed in kernicterus (Steinborn et al., 1999), and an underlying component of a diverse range of diseases and associated neuropathologies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Unconjugated hyperbilirubinemia is a common condition in the first week of postnatal life. Although generally harmless, some neonates may develop very high levels of unconjugated bilirubin (UCB), which may surpass the protective mechanisms of the brain in preventing UCB accumulation. In this case, both short-term and long-term neurodevelopmental disabilities, such as acute and chronic UCB encephalopathy, known as kernicterus, or more subtle alterations defined as bilirubin-induced neurological dysfunction (BIND) may be produced. There is a tremendous variability in babies' vulnerability toward UCB for reasons not yet explained, but preterm birth, sepsis, hypoxia, and hemolytic disease are comprised as risk factors. Therefore, UCB levels and neurological abnormalities are not strictly correlated. Even nowadays, the mechanisms of UCB neurotoxicity are still unclear, as are specific biomarkers, and little is known about lasting sequelae attributable to hyperbilirubinemia. On autopsy, UCB was shown to be within neurons, neuronal processes, and microglia, and to produce loss of neurons, demyelination, and gliosis. In isolated cell cultures, UCB was shown to impair neuronal arborization and to induce the release of pro-inflammatory cytokines from microglia and astrocytes. However, cell dependent sensitivity to UCB toxicity and the role of each nerve cell type remains not fully understood. This review provides a comprehensive insight into cell susceptibilities and molecular targets of UCB in neurons, astrocytes, and oligodendrocytes, and on phenotypic and functional responses of microglia to UCB. Interplay among glia elements and cross-talk with neurons, with a special emphasis in the UCB-induced immunostimulation, and the role of sepsis in BIND pathogenesis are highlighted. New and interesting data on the anti-inflammatory and antioxidant activities of different pharmacological agents are also presented, as novel and promising additional therapeutic approaches to BIND.
    Frontiers in Pharmacology 05/2012; 3:88. DOI:10.3389/fphar.2012.00088 · 3.80 Impact Factor
Show more